Home/Filings/4/0001493152-24-024124
4//SEC Filing

Lawler Joseph F. 4

Accession 0001493152-24-024124

CIK 0001815974other

Filed

Jun 16, 8:00 PM ET

Accepted

Jun 17, 4:23 PM ET

Size

20.3 KB

Accession

0001493152-24-024124

Insider Transaction Report

Form 4
Period: 2024-06-13
Lawler Joseph F.
Director10% Owner
Transactions
  • Award

    Stock Option (right to buy)

    2024-06-13+41,66741,667 total
    Exercise: $2.10Exp: 2034-06-12Common Stock (41,667 underlying)
  • Award

    Stock Option (right to buy)

    2024-06-13+6,6186,618 total
    Exercise: $2.10Exp: 2034-06-12Common Stock (6,618 underlying)
Footnotes (2)
  • [F1]These stock options vest 50% on the date of the 2024 annual meeting of shareholders and 50% on the one year anniversary of the date of grant
  • [F2]These stock options vest on the earlier of November 30,2024 or the date of the 2024 annual meeting of shareholders

Issuer

Anebulo Pharmaceuticals, Inc.

CIK 0001815974

Entity typeother

Related Parties

1
  • filerCIK 0001770401

Filing Metadata

Form type
4
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:23 PM ET
Size
20.3 KB